Evidence map›Paper›PMID 42796440›Full record

ArticleMolecules (Basel, Switzerland)2026

Erinacine C Attenuates Alzheimer's-like Pathology: A Study in APP/PS1 Mice and PC12 Cells.

Li-Yu Wang, Shu-Lan Yeh, Shih-Tien Hsu, Shu-Ming Huang, Chi-Fai Chau, Cheng-Hung Chuang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Li-Yu WangDepartment of Nutrition, Hungkuang University, Taichung 43302, Taiwan.
Shu-Lan YehDepartment of Nutrition, Chung Shan Medical University, Taichung 40203, Taiwan.
Shih-Tien HsuDepartment of Obstetrics and Gynecology and Women's Health, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Shu-Ming HuangDepartment of Nutrition, Hungkuang University, Taichung 43302, Taiwan.
Chi-Fai ChauDepartment of Food Science and Biotechnology, National Chung Hsing University, Taichung 40227, Taiwan.ORCID 0000-0002-6761-7932
Cheng-Hung ChuangDepartment of Nutrition, Hungkuang University, Taichung 43302, Taiwan.ORCID 0000-0003-1963-1825

Funding

National Science and Technology Council 109-2637-B-241-004-National Science and Technology Council 110-2637-B-241-007-
6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta (Aβ) deposition and cognitive decline. Clinical evidence indicates that

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorNeuroprotective AgentsPresenilin-1Amyloid beta-PeptidesAnimalsApoptosisDisease Models, AnimalHericiumHippocampusMiceMice, TransgenicPC12 CellsProto-Oncogene Proteins c-aktRatsSignal TransductionAmyloid beta-PeptidesAmyloid beta-Protein PrecursorNeuroprotective AgentsPresenilin-1Proto-Oncogene Proteins c-aktAkt/GSK3β signalingAlzheimer’s diseaseapoptosisAPP/PS1 miceerinacine CHericium erinaceusneuroinflammationtau phosphorylation

Identifiers

PMID42796440
PMCPMC13609676

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.